Previous Article | Next Article 
Infection and Immunity, August 2006, p. 4927-4931, Vol. 74, No. 8
0019-9567/06/$08.00+0 doi:10.1128/IAI.00491-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Interleukin-10 Inhibits Gram-Negative-Microbe-Specific Human Receptor Activator of NF-
B Ligand-Positive CD4+-Th1-Cell- Associated Alveolar Bone Loss In Vivo
Xiaoxia Zhang and
Yen-Tung A. Teng*
Laboratory of Molecular Microbial Immunity and Division of Periodontology, Eastman Department of Dentistry and Centre for Oral Biology, Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, New York 14620
Received 26 March 2006/
Returned for modification 2 May 2006/
Accepted 5 May 2006
To study anti-inflammatory cytokine effects on RANKL+-T-cell-mediated osteoclastogenesis in vivo, we injected human interleukin-10 (hIL-10) into pathogen-infected HuPBL-NOD/SCID mice. The results show significantly decreased RANKL+ Th1-associated alveolar bone loss and coexpression of human gamma interferon (hIFN-
) and human macrophage colony-stimulating factor, but not hIL-4, in RANKL+ Th cells compatible with those from successfully treated aggressive periodontitis subjects. Thus, there are critical cytokine interactions linking hIFN-
+ Th1 cells to RANKL-RANK/OPG signaling for periodontal osteoclastogenesis in vivo.
* Corresponding author. Mailing address: Laboratory of Molecular Microbial Immunity, Eastman Dental Center and Centre for Oral Biology, Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester Medical Centre, Box-683, 625 Elmwood Ave., Rochester, NY 14620. Phone: (585) 275-7309. Fax: (585) 473-5254. E-mail:
andy_teng{at}urmc.rochester.edu.
Editor: J. B. Bliska
Infection and Immunity, August 2006, p. 4927-4931, Vol. 74, No. 8
0019-9567/06/$08.00+0 doi:10.1128/IAI.00491-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Park-Min, K.-H., Ji, J.-D., Antoniv, T., Reid, A. C., Silver, R. B., Humphrey, M. B., Nakamura, M., Ivashkiv, L. B.
(2009). IL-10 Suppresses Calcium-Mediated Costimulation of Receptor Activator NF-{kappa}B Signaling during Human Osteoclast Differentiation by Inhibiting TREM-2 Expression. J. Immunol.
183: 2444-2455
[Abstract]
[Full Text]
-
Zhang, X., Alnaeeli, M., Singh, B., Teng, Y.-T. A.
(2009). Involvement of SOCS3 in Regulation of CD11c+ Dendritic Cell-Derived Osteoclastogenesis and Severe Alveolar Bone Loss. Infect. Immun.
77: 2000-2009
[Abstract]
[Full Text]
-
Kyung, T.-W., Lee, J.-E., Van Phan, T., Yu, R., Choi, H.-S.
(2009). Osteoclastogenesis by Bone Marrow-Derived Macrophages Is Enhanced in Obese Mice. J. Nutr.
139: 502-506
[Abstract]
[Full Text]
-
Claudino, M., Trombone, A. P. F., Cardoso, C. R., Ferreira, S. B. Jr, Martins, W. Jr, Assis, G. F., Santos, C. F., Trevilatto, P. C., Campanelli, A. P., Silva, J. S., Garlet, G. P.
(2008). The broad effects of the functional IL-10 promoter-592 polymorphism: modulation of IL-10, TIMP-3, and OPG expression and their association with periodontal disease outcome. J. Leukoc. Biol.
84: 1565-1573
[Abstract]
[Full Text]
-
Stashenko, P., Goncalves, R. B., Lipkin, B., Ficarelli, A., Sasaki, H., Campos-Neto, A.
(2007). Th1 Immune Response Promotes Severe Bone Resorption Caused by Porphyromonas gingivalis. Am. J. Pathol.
170: 203-213
[Abstract]
[Full Text]